Case study / TYBR Health

You just got FDA clearance. Now the real work starts.

Post-clearance is when MedTech brands suddenly need content in every direction. Here is how TYBR Health turned that moment into a launch-ready creative system.

TYBR Health B3 Gel System campaign creative

B3 Gel System FDA cleared product creative

B3 Gel System surgery statistic creative

B3 Gel System clinical education creative

The post-clearance scramble

Clearance was hard. Now you have to take it to market.

FDA clearance is a massive milestone. The next challenge is translating that achievement into the content system a launch actually needs.

Teams have to explain the mechanism, support clinical conversations, equip sales and distribution, keep investors aligned, and show up consistently across every market-facing channel. The need is not one asset. It is a whole library.

MOA animation

A clear mechanism-of-action story that shows how the product works, what makes it different, and why the science matters.

Presentations

Sales decks, investor updates, distributor presentations, and clinical education slides that keep the launch story consistent.

Social media rollout

Launch announcements, product education posts, clinical proof points, and ongoing content that keeps the market aware.

Email marketing

Announcement emails, nurture sequences, conference follow-ups, and sales-support messages for different audience segments.

Event materials

Booth graphics, leave-behinds, posters, presentation loops, and quick-hit materials that help the team show up prepared.

Clinical documents

Evidence summaries, product one-pagers, use-case explainers, and review-ready materials for clinical conversations.

The TYBR story

How TYBR built the content arsenal to support their product launch.

ClientTYBR Health

ProductB3 Gel

EngagementLaunch content ecosystem

TYBR Health B3 Gel System business card creative — Brand system

B3 Gel System product poster creative — Launch poster

TYBR Health product brochure creative — Sales brochure

B3 Gel System square clinical creative — Clinical proof

TYBR Health product card creative — Product card

B3 Gel System clinical performance study creative — Study support

The build model

Start with the story. Build the library. Launch with everything aligned.

Every launch starts in a slightly different place. For TYBR, the first anchor was a 90-second motion animation that could explain B3 Gel clearly and give the team a shared story to build from.

Start with the story

The animation helped translate the clinical problem, mechanism, product value, and launch narrative into one clear sequence.

Build the library

From that source asset, we created product renderings, still frames, mechanism visuals, and clinical graphics the team could reuse everywhere.

Launch aligned

That library made the website, sales and marketing materials, clinical brochures, and other launch assets faster and more consistent to produce.

How this works

Turning one anchor story into a launch library.

A short walkthrough on starting with a larger source asset, then extracting the visual and strategic pieces that make the website, sales materials, and clinical education easier to build.

Client response

In TYBR's words.

All testimonials →

The Vuelab team have been true partners in this process. They didn't just execute our vision - they enhanced it with their experience and creative approach. The assets they've created will be central to our launch strategy and ongoing marketing efforts.

Chris Wright

VP of Business Development, TYBR Health

The Vuelab team truly understood what we were trying to accomplish with our B3 GEL™ visualization. They took our scientific concepts and translated them into sophisticated, modern visuals that will resonate with surgeons while maintaining the scientific integrity we needed.

Ian Dawson

Strategic Marketing, TYBR Health

Turn clearance into a launch-ready content system.

In 30 minutes, we'll map the story, assets, and production path your team needs to move from approval to market.

FAQs

Questions you are already asking.

We just got clearance. What should we build first?

Start with the clearest source story: usually an MOA, product animation, or launch narrative that explains the product, the problem, and the clinical value. From there, the rest of the content library becomes much easier to produce.

Do we need one hero asset or a full launch library?

Most post-clearance teams need both. The hero asset gives everyone a shared story. The library gives sales, marketing, clinical, investor, and event teams the pieces they need to show up consistently.

Can you work from technical documents and early product materials?

Yes. We can build from IFUs, clinical papers, pitch decks, CAD, product photography, prototypes, and internal documentation. Part of the work is turning scattered source material into a usable content system.

How do you keep the content clinically accurate?

We work from approved claims, source documentation, and your review process. The goal is to make the product easier to understand without inventing claims or drifting away from the science.

What assets typically come out of this kind of engagement?

MOA animations, product renderings, launch decks, website visuals, sales materials, clinical brochures, social content, email graphics, event materials, and investor-facing visuals.

How early should we bring Vuelab in?

Ideally before the launch scramble starts. Once clearance lands, teams often need a lot of content quickly, and the work is stronger when the story, visual language, and asset plan are built together.